A review of matched-sample benchmarking studies finds standard RNA-seq recovers only 3–5% of TCR clonotypes identified by ...

Single-cell and multi-omics analyses of hepatocellular carcinoma point to IL-1β-positive macrophages and IL-1R1-positive ...

Researchers identified RNA-associated amyloid fibrils in human seminal fluid and demonstrated that synthetic PAP fibrils ...

Rotow, MD, explains how RNA-based next-generation sequencing (NGS) fits into testing for newly diagnosed advanced nonsquamous non-small cell lung cancer (NSCLC) in a discussion moderated by Matthew A.

Tempus AI, Inc. (NASDAQ: TEM) today announced that its xR assay has received certification under the European Union’s In Vitro Diagnostic Regulation (IVDR) as a Class C in vitro diagnostic device. The ...

Tempus xR RNA sequencing assay receives EU IVDR Class C certification, supporting continued clinical and biopharma access in ...

Scientists have discovered that a “fruitless” gene in the species is responsible for the male’s ability to locate and mate ...

Precision-cut lung slices allow researchers to study living human lung tissue outside the body, preserving the different cell ...

To prevent the spread of dangerous diseases by mosquitoes, scientists have long studied their reproductive mechanisms to ...

A personalized melanoma vaccine, called intismeran, could mark a major advance in cancer treatment. Last week, pharmaceutical ...

Tempus AI (TEM) said Monday its xR solid tumor profiling assay has received Class C certification under the European Union's In Vitro Diagnostic Regulation for cancer genomic profiling. The company ...

New RNA extraction techniques overcome barriers to help scientists better evaluate treatments for diseases such as pulmonary ...